Trial intelligence / Profile preview

Alfentanil pre-injection with remimazolam induction for gynecological day surgery

ChiCTR2300075911Phase 4Recruiting

Sponsor
Weifang People's Hospital
Start
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of alfentanil (2 arms), sponsored by Weifang People's Hospital. Primary endpoint: Time to induction of anesthesia. Started Oct 2023; status: recruiting.

02

Drugs

alfentanil

Beyond the preview

Go deeper on ChiCTR2300075911.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300075911.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call